Last Price$68.62.5%
Market Cap$2,075.9M
N/A
Industry median - 13.4%
5Y Historical average - N/A
12.9%
Industry median - 0.3%
5Y Historical average - 131.4%
(100.0%)
Industry median - (20.6%)
5Y Historical average - 388,545.0%
(100.0%)
Industry median - (1.7%)
5Y Historical average - 6,916.8%
BLTE Growth Rating
BLTE Growth rating
5.1
BLTE Growth rating performance
BLTE Growth Metrics
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
Competing with BLTE Growth
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Growth score | Revenue Growth
(5Y CAGR) | Revenue Growth
(YoY) | Revenue Growth
(FWD) | EPS Growth
(5Y CAGR) | EPS Growth
(YoY) | EPS Growth
(FWD) | FCF Growth
(5Y CAGR) | FCF Growth
(YoY) |
$2,075.9M | 5.1 | N/A | N/A | N/A | N/A | (100.0%) | (1.5%) | N/A | (100.0%) | |
$124.8B | 6.9 | 21.5% | 11.5% | 8.6% | N/A | N/A | (962.4%) | N/A | N/A | |
$77.0B | 5.6 | 12.6% | 8.3% | 2.4% | 16.1% | 10.3% | 3.1% | 12.5% | (5.7%) | |
$34.4B | 6.3 | 106.9% | 127.3% | 76.3% | (9.7%) | (57.5%) | (132.2%) | N/A | (70.8%) | |
$30.7B | 5.4 | 59.2% | 23.0% | 28.6% | (23.2%) | (38.5%) | (26.5%) | (36.7%) | N/A | |
$24.0B | 6.2 | 90.9% | (28.0%) | (28.0%) | 36.5% | N/A | (182.9%) | (3.1%) | N/A | |
$14.5B | 4.0 | 4.5% | (3.8%) | 35.4% | (19.0%) | (9.0%) | 144.6% | 10.7% | (7.3%) | |
$13.8B | 7.5 | 14.7% | 23.6% | 9.1% | N/A | 25.6% | 6.8% | N/A | 44.5% | |
$13.4B | 7.1 | 10.8% | 17.8% | 10.0% | N/A | 152.8% | 48.9% | N/A | 820.5% | |
$13.3B | 6.1 | (100.0%) | N/A | N/A | (0.9%) | (92.8%) | 11.4% | 44.6% | 84.8% | |
$1,846.9M | 5.9 | 50.5% | 50.5% | 50.7% | 25.3% | 20.9% | (35.6%) | 3.3% | (43.8%) |
FAQ
What is the Belite Bio, Inc (BLTE) revenue growth?
The Belite Bio, Inc (BLTE) revenue growth is N/A, which is lower than the industry median of 13.4% and the 5-year historical average of N/A.
What is the Belite Bio, Inc (BLTE) operating income growth?
The Belite Bio, Inc (BLTE) operating income growth is 12.9%, compared to the industry median of 0.3% and the 5-year historical average of 131.4%.
What is the Belite Bio, Inc (BLTE) EPS (Earnings Per Share) growth?
The Belite Bio, Inc (BLTE) EPS growth is (100.0%), compared to the industry median of (20.6%) and the 5-year historical average of 388,545.0%.
What is the Belite Bio, Inc (BLTE) Free Cash Flow (FCF) growth?
The Belite Bio, Inc (BLTE) Free Cash Flow growth is (100.0%), compared to the industry median of (1.7%) and the 5-year historical average of 6,916.8%.